ABEO Price Targets and Analyst Ratings NASDAQ:ABEO
ABEO Forecast. What You Should Know.
ABEO Historical Ratings and Targets
About Abeona Therapeutics Inc.
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;... ABEO Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.